If you are interested in investing in a high quality large pharmaceutical company, two of your primary choices would be Pfizer (PFE) or Merck (MRK), of course, Merck being the largest. Which one of these investments would suit you better as an investor?
In this video, Chuck Carnevale, Co-founder of FAST Graphs, a.k.a. Mr. Valuation is going to answer that question – it depends on what your goals, objectives and risk tolerances are.
Try FAST Graphs for FREE Today!
SUBSCRIBE to our YouTube Channel
Click here for our Research Articles
Disclosure: Long PFE, MRK
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.
FAST Graphs™ is a stock research tool that empowers subscribers to conduct fundamental stock research deeper and faster than ever before.
